Intervention Protocol

Glucose lowering therapies for chronic kidney disease and kidney transplantation

  1. Min Jun1,
  2. Clement Lo2,
  3. Sunil V Badve3,
  4. Helen Pilmore4,
  5. Sarah L White1,
  6. Carmel Hawley3,
  7. Alan Cass1,
  8. Vlado Perkovic1,
  9. Sophia Zoungas1,2,*

Editorial Group: Cochrane Renal Group

Published Online: 15 AUG 2012

DOI: 10.1002/14651858.CD009966

How to Cite

Jun M, Lo C, Badve SV, Pilmore H, White SL, Hawley C, Cass A, Perkovic V, Zoungas S. Glucose lowering therapies for chronic kidney disease and kidney transplantation (Protocol). Cochrane Database of Systematic Reviews 2012, Issue 8. Art. No.: CD009966. DOI: 10.1002/14651858.CD009966.

Author Information

  1. 1

    The George Institute for Global Health, Renal and Metabolic Division, Camperdown, NSW, Australia

  2. 2

    Monash University, School of Public Health and Preventive Medicine, Monash Applied Research Stream, Clayton, VIC, Australia

  3. 3

    Princess Alexandra Hospital, Department of Nephrology, Woolloongabba, QLD, Australia

  4. 4

    Auckland Hospital, Department of Renal Medicine, Grafton, Auckland, New Zealand

*Sophia Zoungas, szoungas@georgeinstitute.org.au.

Publication History

  1. Publication Status: New
  2. Published Online: 15 AUG 2012

SEARCH

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

The objective of this review is to study the safety and efficacy of glucose lowering therapies in patients with CKD.